Access cutting-edge acute myeloid leukemia treatment through this clinical trial at a research site in Berkeley. Study-provided care at no cost to qualified participants.
Access acute myeloid leukemia specialists in Berkeley at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute myeloid leukemia treatment provided free
This phase II MyeloMATCH treatment trial tests whether the standard approach of cytarabine and daunorubicin in comparison to the following experimental regimens works to shrink cancer in patients with high risk acute myeloid leukemia (AML): 1) daunorubicin and cytarabine liposome alone; 2) cytarabine and daunorubicin with venetoclax; 3) azacitidine and venetoclax; 4) daunorubicin and cytarabine liposome and venetoclax. "High-risk" refers to traits that have been known to make the AML harder to t
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this acute myeloid leukemia clinical trial in Berkeley, CA
If you're searching for acute myeloid leukemia treatment options in Berkeley, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Berkeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute myeloid leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.